Bhandari Polyclinic Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.15 M
as on 19-12-2024
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.33 M
as on 19-12-2024
- Revenue 10.20%
(FY 2020)
- Profit 39.87%
(FY 2020)
- Ebitda 48.53%
(FY 2020)
- Net Worth 17.23%
(FY 2020)
- Total Assets 44.82%
(FY 2020)
About Bhandari Polyclinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹2.33 M.
Ajay Bhandari, Rajeev Bhandari, Aruna Bhandari, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MP1990PTC005917
- Company No.
005917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationJabalpur., Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhandari Polyclinic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Bhandari  | Managing Director | 19-Jul-1990 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Bhandari | Director | 01-Apr-1998 | Current |
| Rajeev Bhandari | Director | 19-Jul-1990 | Current |
| Rohit Bhandari | Director | 02-Mar-2022 | Current |
Financial Performance of Bhandari Polyclinic.
Bhandari Polyclinic Pvt Ltd, for the financial year ended 2020, experienced significant growth in revenue, with a 10.2% increase. The company also saw a substantial improvement in profitability, with a 39.87% increase in profit. The company's net worth Soared by an impressive increase of 17.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhandari Polyclinic?
In 2020, Bhandari Polyclinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bhandari Multi-Speciality Healthcare Private LimitedActive 1 month 8 days
Ajay Bhandari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 16 Aug 2005 | ₹0.50 M | Open |
Punjab National Bank Creation Date: 23 Aug 1999 | ₹0.36 M | Open |
Punjab National Bank Creation Date: 27 Mar 1991 | ₹1.47 M | Open |
How Many Employees Work at Bhandari Polyclinic?
Unlock and access historical data on people associated with Bhandari Polyclinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhandari Polyclinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhandari Polyclinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
